Screener
CONMED CNMD Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfSeniorDebt.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Other | — | 850 |
| Net cash provided by (used in) investing activities | 15,674 | (8,658) |
| Cash flows from financing activities: | ||
| Payments on term loan | — | (54,821) |
| Proceeds from term loan | 450,000 | 25,234 |
| Payments on revolving line of credit | (402,000) | (337,432) |
| Proceeds from revolving line of credit | 595,000 | 341,432 |
| Repurchases of common stock | (43,221) | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's debt repayments?
- CONMED (CNMD) reported debt repayments of $0 in Q2 2026.
- How has CONMED's debt repayments changed year-over-year?
- CONMED's debt repayments decreased by 100.0% year-over-year, from $40.23M to $0.
- What is the long-term trend for CONMED's debt repayments?
- Over 3 years (2021 to 2025), CONMED's debt repayments has grown at a 14.4% compound annual growth rate (CAGR), from $66.65M to $99.82M.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.
Ask your AI about CONMED's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude